mFOLFOX6+Bevacizumab+PD-1 Monoclonal Antibody in Local Advanced MSS CRC
Condition(s):Colorectal Cancer; ImmunotherapyLast Updated:July 13, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Colorectal Cancer; ImmunotherapyLast Updated:July 13, 2023Recruiting
Condition(s):Metastatic Colon CancerLast Updated:March 28, 2024Not yet recruiting
Condition(s):Colorectal Cancer; Liver MetastasesLast Updated:July 17, 2023Not yet recruiting
Condition(s):Colorectal CancerLast Updated:August 25, 2023Recruiting
Condition(s):Biliary Tract CancerLast Updated:May 10, 2023Recruiting
Condition(s):Colorectal CancerLast Updated:October 7, 2022Not yet recruiting
Condition(s):Advanced Pancreatic CancerLast Updated:March 26, 2024Not yet recruiting
Condition(s):Colorectal CancerLast Updated:January 20, 2022Recruiting
Condition(s):Colorectal CancerLast Updated:January 2, 2024Recruiting
Condition(s):Chemo-refractory Colorectal CarcinomaLast Updated:June 15, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.